Literature DB >> 8410998

Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.

D M Zimmerman1, J D Leander, B E Cantrell, J K Reel, J Snoddy, L G Mendelsohn, B G Johnson, C H Mitch.   

Abstract

A series of racemic N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines were evaluated for opioid agonist and antagonist activity at mu and kappa receptors. Several highly potent mu and kappa antagonists were discovered; however, no compounds with high selectivity for either the mu or kappa receptor were identified. Importantly, no derivative was found to have significant opioid agonist activity. Two derivatives were resolved, and the activities of the enantiomers were investigated. Only a limited stereochemical effect on opioid receptor selectivities was observed. The structure-activity relationships described establish the existence of an important lipophilic binding site distal to the nitrogen for both mu and kappa receptors and confirm the pure opioid antagonist pharmacophore nature of the trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410998     DOI: 10.1021/jm00072a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  Kappa opioid antagonists: past successes and future prospects.

Authors:  Matthew D Metcalf; Andrew Coop
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

2.  N-substituted cis-4a-(3-hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists.

Authors:  F Ivy Carroll; Sachin Chaudhari; James B Thomas; S Wayne Mascarella; Kenneth M Gigstad; Jeffrey Deschamps; Hernán A Navarro
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

3.  Chemical structural novelty: on-targets and off-targets.

Authors:  Emmanuel R Yera; Ann E Cleves; Ajay N Jain
Journal:  J Med Chem       Date:  2011-09-14       Impact factor: 7.446

4.  Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonists.

Authors:  Chad M Kormos; Chunyang Jin; Juan Pablo Cueva; Scott P Runyon; James B Thomas; Lawrence E Brieaddy; S Wayne Mascarella; Hernán A Navarro; Brian P Gilmour; F Ivy Carroll
Journal:  J Med Chem       Date:  2013-05-16       Impact factor: 7.446

Review 5.  The discovery and development of the N-substituted trans-3,4-dimethyl-4-(3'-hydroxyphenyl)piperidine class of pure opioid receptor antagonists.

Authors:  F Ivy Carroll; Roland E Dolle
Journal:  ChemMedChem       Date:  2014-06-30       Impact factor: 3.466

6.  1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists.

Authors:  F Ivy Carroll; Juan Pablo Cueva; James B Thomas; S Wayne Mascarella; Scott P Runyon; Hernán A Navarro
Journal:  ACS Med Chem Lett       Date:  2010-10-14       Impact factor: 4.345

7.  Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).

Authors:  Juan Pablo Cueva; Tingwei Bill Cai; S Wayne Mascarella; James B Thomas; Hernán A Navarro; F Ivy Carroll
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

Review 8.  Development of κ opioid receptor antagonists.

Authors:  F Ivy Carroll; William A Carlezon
Journal:  J Med Chem       Date:  2013-02-14       Impact factor: 7.446

9.  4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist.

Authors:  F Ivy Carroll; Moses G Gichinga; John D Williams; Eyal Vardy; Bryan L Roth; S Wayne Mascarella; James B Thomas; Hernán A Navarro
Journal:  J Med Chem       Date:  2013-11-05       Impact factor: 7.446

10.  "In silico" study of the binding of two novel antagonists to the nociceptin receptor.

Authors:  Stefano Della Longa; Alessandro Arcovito
Journal:  J Comput Aided Mol Des       Date:  2018-01-16       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.